“Shareholders of Aarti industries will get one share of Aarti Pharma labs for 4 shares of Aarti Industries. The company is going to unlock value for its shareholders while the ratio is not very encouraging therefore we saw a muted reaction in the stock price today but it’s both vertical are doing very well. The Pharma business has EBIT margins of 23 percent and has been growing at a CAGR of 20 percent for the past 5 years,” said Santosh Meena , Head of Research at Swastika Investmart.
He further said, “The overall view is bullish for both the verticals therefore investors should hold the stock and take benefit of value unlocking.”
News Source:- Moneycontrol